Transcriptional and epigenetic regulatory mechanisms affecting HTLV-1 provirus

Viruses

Volumn 8, Issue 6, 2016, Pages

  Miyazato, Paola ^a   Matsuo, Misaki ^a   Katsuya, Hiroo ^a   Satou, Yorifumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

HTLV 1 2; Provirus 3; Retroviral latency

Indexed keywords

T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR CTCF;

ALTERNATIVE RNA SPLICING; DNA INTEGRATION; DNA METHYLATION; DNA STRUCTURE; EPIGENETICS; GENE EXPRESSION; GENE MUTATION; HISTONE MODIFICATION; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOGENICITY; INSULATOR REGION; LONG TERMINAL REPEAT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; PROTEIN EXPRESSION; PROVIRUS; REVIEW; RNA SEQUENCE; T CELL LEUKEMIA; TATA BOX; TRANSCRIPTION INITIATION; VIRUS GENOME; VIRUS LATENCY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS;

EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROVIRUSES; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 84975127137     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v8060171     Document Type: Review

References (107)

1. Van Dooren, S.; Salemi, M.; Vandamme, A.M. Dating the origin of the african human T-cell lymphotropic virus type-1 (HTLV-1) subtypes. Mol. Biol. Evol. 2001, 18, 661-671. [CrossRef] [PubMed]
2. Igakura, T.; Stinchcombe, J.C.; Goon, P.K.; Taylor, G.P.; Weber, J.N.; Griffiths, G.M.; Tanaka, Y.; Osame, M.; Bangham, C.R. Spread of HTLV-1 between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299, 1713-1716. [CrossRef] [PubMed]
3. Matsuoka, M.; Jeang, K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 2007, 7, 270-280. [CrossRef] [PubMed]
4. Pais-Correia, A.M.; Sachse, M.; Guadagnini, S.; Robbiati, V.; Lasserre, R.; Gessain, A.; Gout, O.; Alcover, A.; Thoulouze, M.I. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 2010, 16, 83-89. [CrossRef] [PubMed]
5. Bangham, C.R. CTL quality and the control of human retroviral infections. Eur. J. Immunol. 2009, 39, 1700-1712. [CrossRef] [PubMed]
6. Iwanaga, M.; Watanabe, T.; Utsunomiya, A.; Okayama, A.; Uchimaru, K.; Koh, K.R.; Ogata, M.; Kikuchi, H.; Sagara, Y.; Uozumi, K. et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: A nationwide prospective study in japan. Blood 2010, 116, 1211-1219. [CrossRef] [PubMed]
7. Ruelas, D.S.; Greene, W.C. An integrated overview of HIV-1 latency. Cell 2013, 155, 519-529. [CrossRef] [PubMed]
8. Jacobson, S.; Shida, H.; McFarlin, D.E.; Fauci, A.S.; Koenig, S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-1 px in patients with HTLV-1 associated neurological disease. Nature 1990, 348, 245-248. [CrossRef] [PubMed]
9. Kannagi, M.; Harada, S.; Maruyama, I.; Inoko, H.; Igarashi, H.; Kuwashima, G.; Sato, S.; Morita, M.; Kidokoro, M.; Sugimoto, M. et al. Predominant recognition of human T cell leukemia virus type i (HTLV-1) px gene products by human CD8+ cytotoxic T cells directed against HTLV-1-infected cells. Int. Immunol. 1991, 3, 761-767. [CrossRef] [PubMed]
10. Poiesz, B.J.; Ruscetti, F.W.; Gazdar, A.F.; Bunn, P.A.; Minna, J.D.; Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 1980, 77, 7415-7419. [CrossRef] [PubMed]
11. Gallo, R.C. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2005, 2, 17. [CrossRef] [PubMed]
12. Seiki, M.; Hattori, S.; Hirayama, Y.; Yoshida, M. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. USA 1983, 80, 3618-3622. [CrossRef] [PubMed]
13. Zhao, T. The role of HBZ in HTLV-1-induced oncogenesis. Viruses 2016, 8. [CrossRef] [PubMed]
14. Valeri, V.W.; Hryniewicz, A.; Andresen, V.; Jones, K.; Fenizia, C.; Bialuk, I.; Chung, H.K.; Fukumoto, R.; Parks, R.W.; Ferrari, M.G. et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010, 116, 3809-3817. [CrossRef] [PubMed]
15. Andresen, V.; Pise-Masison, C.A.; Sinha-Datta, U.; Bellon, M.; Valeri, V.; Washington Parks, R.; Cecchinato, V.; Fukumoto, R.; Nicot, C.; Franchini, G. Suppression of HTLV-1 replication by tax-mediated rerouting of the p13 viral protein to nuclear speckles. Blood 2011, 118, 1549-1559. [CrossRef] [PubMed]
16. Zazopoulos, E.; Sodroski, J.G.; Haseltine, W.A. P21rex protein of HTLV-1. J. Acquir. Immune Defic. Syndr. 1990, 3, 1135-1139. [PubMed]
17. Silic-Benussi, M.; Biasiotto, R.; Andresen, V.; Franchini, G.; D’Agostino, D.M.; Ciminale, V. HTLV-1 p13, a small protein with a busy agenda. Mol. Asp. Med. 2010, 31, 350-358. [CrossRef] [PubMed]
18. Silic-Benussi, M.; Cavallari, I.; Vajente, N.; Vidali, S.; Chieco-Bianchi, L.; Di Lisa, F.; Saggioro, D.; D’Agostino, D.M.; Ciminale, V. Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: Distinct effects in primary versus transformed cells. Blood 2010, 116, 54-62. [CrossRef] [PubMed]
19. Gaudray, G.; Gachon, F.; Basbous, J.; Biard-Piechaczyk, M.; Devaux, C.; Mesnard, J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76, 12813-12822. [CrossRef] [PubMed]
20. Tirosh, I.; Weinberger, A.; Carmi, M.; Barkai, N. A genetic signature of interspecies variations in gene expression. Nat. Genet. 2006, 38, 830-834. [CrossRef] [PubMed]
21. Landry, C.R.; Lemos, B.; Rifkin, S.A.; Dickinson, W.J.; Hartl, D.L. Genetic properties influencing the evolvability of gene expression. Science 2007, 317, 118-121. [CrossRef] [PubMed]
22. Yoshida, M.; Satou, Y.; Yasunaga, J.; Fujisawa, J.; Matsuoka, M. Transcriptional control of spliced and unspliced human T-cell leukemia virus type 1 bZIP factor (HBZ) gene. J. Virol. 2008, 82, 9359-9368. [CrossRef] [PubMed]
23. Arpin-Andre, C.; Laverdure, S.; Barbeau, B.; Gross, A.; Mesnard, J.M. Construction of a reporter vector for analysis of bidirectional transcriptional activity of retrovirus LTR. Plasmid 2014, 74, 45-51. [CrossRef] [PubMed]
24. Fujisawa, J.; Seiki, M.; Kiyokawa, T.; Yoshida, M. Functional activation of the long terminal repeat of human T-cell leukemia virus type 1 by a trans-acting factor. Proc. Natl. Acad. Sci. USA 1985, 82, 2277-2281. [CrossRef] [PubMed]
25. Yoshida, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 2001, 19, 475-496. [CrossRef] [PubMed]
26. Laverdure, S.; Polakowski, N.; Hoang, K.; Lemasson, I. Permissive sense and antisense transcription from the 51 and 31 long terminal repeats of human T-cell leukemia virus type 1. J. Virol. 2016, 90, 3600-3610. [CrossRef] [PubMed]
27. Lin, H.C.; Hickey, M.; Hsu, L.; Medina, D.; Rabson, A.B. Activation of human T cell leukemia virus type 1 LTR promoter and cellular promoter elements by T cell receptor signaling and HTLV-1 tax expression. Virology 2005, 339, 1-11. [CrossRef] [PubMed]
28. Zhang, W.; Nisbet, J.W.; Bartoe, J.T.; Ding, W.; Lairmore, M.D. Human t-lymphotropic virus type 1 p30(ii) functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 2000, 74, 11270-11277. [CrossRef] [PubMed]
29. Zhang, W.; Nisbet, J.W.; Albrecht, B.; Ding, W.; Kashanchi, F.; Bartoe, J.T.; Lairmore, M.D. Human t-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J. Virol. 2001, 75, 9885-9895. [CrossRef] [PubMed]
30. Nicot, C.; Dundr, M.; Johnson, J.M.; Fullen, J.R.; Alonzo, N.; Fukumoto, R.; Princler, G.L.; Derse, D.; Misteli, T.; Franchini, G. HTLV-1-encoded p30ii is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10, 197-201. [CrossRef] [PubMed]
31. Lemasson, I.; Lewis, M.R.; Polakowski, N.; Hivin, P.; Cavanagh, M.H.; Thebault, S.; Barbeau, B.; Nyborg, J.K.; Mesnard, J.M. Human T-cell leukemia virus type 1 (HTLV-1) bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1 transcription. J. Virol. 2007, 81, 1543-1553. [CrossRef] [PubMed]
32. Clerc, I.; Polakowski, N.; Andre-Arpin, C.; Cook, P.; Barbeau, B.; Mesnard, J.M.; Lemasson, I. An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ. J. Biol. Chem. 2008, 283, 23903-23913. [CrossRef] [PubMed]
33. Murata, K.; Hayashibara, T.; Sugahara, K.; Uemura, A.; Yamaguchi, T.; Harasawa, H.; Hasegawa, H.; Tsuruda, K.; Okazaki, T.; Koji, T. et al. A novel alteRNAtive splicing isoform of human T-cell leukemia virus type 1 bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 2006, 80, 2495-2505. [CrossRef] [PubMed]
34. Satou, Y.; Yasunaga, J.; Yoshida, M.; Matsuoka, M. HTLV-1 basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 2006, 103, 720-725. [CrossRef] [PubMed]
35. Gazon, H.; Lemasson, I.; Polakowski, N.; Cesaire, R.; Matsuoka, M.; Barbeau, B.; Mesnard, J.M.; Peloponese, J.M., Jr. Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor jund to upregulate HTLV-1 antisense transcription from the 31 long terminal repeat. J. Virol. 2012, 86, 9070-9078. [CrossRef] [PubMed]
36. Grassmann, R.; Berchtold, S.; Radant, I.; Alt, M.; Fleckenstein, B.; Sodroski, J.G.; Haseltine, W.A.; Ramstedt, U. Role of human T-cell leukemia virus type 1 x region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 1992, 66, 4570-4575. [PubMed]
37. Akagi, T.; Shimotohno, K. Proliferative response of tax1-transduced primary human T cells to anti-cd3 antibody stimulation by an interleukin-2-independent pathway. J. Virol. 1993, 67, 1211-1217. [PubMed]
38. Akagi, T.; Ono, H.; Shimotohno, K. Characterization of T cells immortalized by tax1 of human T-cell leukemia virus type 1. Blood 1995, 86, 4243-4249. [PubMed]
39. Maeda, M.; Shimizu, A.; Ikuta, K.; Okamoto, H.; Kashihara, M.; Uchiyama, T.; Honjo, T.; Yodoi, J. Origin of human t-lymphotrophic virus i-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J. Exp. Med. 1985, 162, 2169-2174. [CrossRef] [PubMed]
40. Furukawa, Y.; Kubota, R.; Tara, M.; Izumo, S.; Osame, M. Existence of escape mutant in HTLV-1 tax during the development of adult T-cell leukemia. Blood 2001, 97, 987-993. [CrossRef] [PubMed]
41. Takeda, S.; Maeda, M.; Morikawa, S.; Taniguchi, Y.; Yasunaga, J.; Nosaka, K.; Tanaka, Y.; Matsuoka, M. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer 2004, 109, 559-567. [CrossRef] [PubMed]
42. Nosaka, K.; Maeda, M.; Tamiya, S.; Sakai, T.; Mitsuya, H.; Matsuoka, M. Increasing methylation of the cdkn2a gene is associated with the progression of adult T-cell leukemia. Cancer Res. 2000, 60, 1043-1048. [PubMed]
43. Yasunaga, J.; Taniguchi, Y.; Nosaka, K.; Yoshida, M.; Satou, Y.; Sakai, T.; Mitsuya, H.; Matsuoka, M. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res. 2004, 64, 6002-6009. [CrossRef] [PubMed]
44. Yoshida, M.; Nosaka, K.; Yasunaga, J.; Nishikata, I.; Morishita, K.; Matsuoka, M. Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 2004, 103, 2753-2760. [CrossRef] [PubMed]
45. Hidaka, T.; Nakahata, S.; Hatakeyama, K.; Hamasaki, M.; Yamashita, K.; Kohno, T.; Arai, Y.; Taki, T.; Nishida, K.; Okayama, A. et al. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood 2008, 112, 383-393. [CrossRef] [PubMed]
46. Yamagishi, M.; Nakano, K.; Miyake, A.; Yamochi, T.; Kagami, Y.; Tsutsumi, A.; Matsuda, Y.; Sato-Otsubo, A.; Muto, S.; Utsunomiya, A. et al. Polycomb-mediated loss of mir-31 activates nik-dependent nf-kappab pathway in adult T cell leukemia and other cancers. Cancer Cell 2012, 21, 121-135. [CrossRef] [PubMed]
47. Kataoka, K.; Nagata, Y.; Kitanaka, A.; Shiraishi, Y.; Shimamura, T.; Yasunaga, J.; Totoki, Y.; Chiba, K.; Sato-Otsubo, A.; Nagae, G. et al. Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat. Genet. 2015, 47, 1304-1315. [CrossRef] [PubMed]
48. Fujikawa, D.; Nakagawa, S.; Hori, M.; Kurokawa, N.; Soejima, A.; Nakano, K.; Yamochi, T.; Nakashima, M.; Kobayashi, S.; Tanaka, Y. et al. Polycomb-dependent epigenetic landscape in adult T-cell leukemia. Blood 2016, 127, 1790-1802. [CrossRef] [PubMed]
49. Nagata, Y.; Kontani, K.; Enami, T.; Kataoka, K.; Ishii, R.; Totoki, Y.; Kataoka, T.R.; Hirata, M.; Aoki, K.; Nakano, K. et al. Variegated RHOA mutations in adult T-cell leukemia/lymphoma. Blood 2016, 127, 596-604. [CrossRef] [PubMed]
50. Nakagawa, M.; Schmitz, R.; Xiao, W.; Goldman, C.K.; Xu, W.; Yang, Y.; Yu, X.; Waldmann, T.A.; Staudt, L.M. Gain-of-function ccr4 mutations in adult T cell leukemia/lymphoma. J. Exp. Med. 2014, 211, 2497-2505. [CrossRef] [PubMed]
51. Belrose, G.; Gross, A.; Olindo, S.; Lezin, A.; Dueymes, M.; Komla-Soukha, I.; Smadja, D.; Tanaka, Y.; Willems, L.; Mesnard, J.M. et al. Effects of valproate on tax and HBZ expression in HTLV-1 and ham/tsp T lymphocytes. Blood 2011, 118, 2483-2491. [CrossRef] [PubMed]
52. Usui, T.; Yanagihara, K.; Tsukasaki, K.; Murata, K.; Hasegawa, H.; Yamada, Y.; Kamihira, S. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in HTLV-1 provirus-positive cells. Retrovirology 2008, 5, 34. [CrossRef] [PubMed]
53. Macnamara, A.; Rowan, A.; Hilburn, S.; Kadolsky, U.; Fujiwara, H.; Suemori, K.; Yasukawa, M.; Taylor, G.; Bangham, C.R.; Asquith, B. Hla class i binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog. 2010, 6. [CrossRef] [PubMed]
54. Clarke, M.F.; Trainor, C.D.; Mann, D.L.; Gallo, R.C.; Reitz, M.S. Methylation of human T-cell leukemia virus proviral DNA and viral RNA expression in short-and long-term cultures of infected cells. Virology 1984, 135, 97-104. [CrossRef]
55. Hanon, E.; Hall, S.; Taylor, G.P.; Saito, M.; Davis, R.; Tanaka, Y.; Usuku, K.; Osame, M.; Weber, J.N.; Bangham, C.R. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type i (HTLV-1) is prevented by cytotoxic T lymphocytes. Blood 2000, 95, 1386-1392. [PubMed]
56. Satou, Y.; Utsunomiya, A.; Tanabe, J.; Nakagawa, M.; Nosaka, K.; Matsuoka, M. HTLV-1 modulates the frequency and phenotype of foxp3+CD4+ T cells in virus-infected individuals. Retrovirology 2012, 9, 46. [CrossRef] [PubMed]
57. Rende, F.; Cavallari, I.; Corradin, A.; Silic-Benussi, M.; Toulza, F.; Toffolo, G.M.; Tanaka, Y.; Jacobson, S.; Taylor, G.P.; D’Agostino, D.M. et al. Kinetics and intracellular compartmentalization of HTLV-1 gene expression: Nuclear retention of HBZ mRNAs. Blood 2011, 117, 4855-4859. [CrossRef] [PubMed]
58. Cavallari, I.; Rende, F.; Ciminale, V. Quantitative analysis of human t-lymphotropic virus type 1 (HTLV-1) gene expression using nucleo-cytoplasmic fractionation and splice junction-specific real-time rt-pcr (qrt-pcr). Methods Mol. Biol. 2014, 1087, 325-337. [PubMed]
59. Cavallari, I.; Rende, F.; Bona, M.K.; Sztuba-Solinska, J.; Silic-Benussi, M.; Tognon, M.; LeGrice, S.F.; Franchini, G.; D’Agostino, D.M.; Ciminale, V. Expression of alternatively spliced human T-cell leukemia virus type 1 mRNAs is influenced by mitosis and by a novel cis-acting regulatory sequence. J. Virol. 2016, 90, 1486-1498. [CrossRef] [PubMed]
60. Mitobe, Y.; Yasunaga, J.; Furuta, R.; Matsuoka, M. HTLV-1 bZIP factor RNA and protein impart distinct functions on T-cell proliferation and survival. Cancer Res. 2015, 75, 4143-4152. [CrossRef] [PubMed]
61. Satou, Y.; Matsuoka, M. Implication of the HTLV-1 bZIP factor gene in the leukemogenesis of adult T-cell leukemia. Int. J. Hematol. 2007, 86, 107-112. [CrossRef] [PubMed]
62. Ma, G.; Yasunaga, J.; Matsuoka, M. Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology 2016, 13, 16. [CrossRef] [PubMed]
63. Cavanagh, M.H.; Landry, S.; Audet, B.; Arpin-Andre, C.; Hivin, P.; Pare, M.E.; Thete, J.; Wattel, E.; Marriott, S.J.; Mesnard, J.M. et al. HTLV-1 antisense transcripts initiating in the 31LTR are alternatively spliced and polyadenylated. Retrovirology 2006, 3, 15. [CrossRef] [PubMed]
64. Gillet, N.A.; Malani, N.; Melamed, A.; Gormley, N.; Carter, R.; Bentley, D.; Berry, C.; Bushman, F.D.; Taylor, G.P.; Bangham, C.R. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011, 117, 3113-3122. [CrossRef] [PubMed]
65. Melamed, A.; Laydon, D.J.; Gillet, N.A.; Tanaka, Y.; Taylor, G.P.; Bangham, C.R. Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. PLoS Pathog. 2013, 9, e1003271. [CrossRef] [PubMed]
66. Bangham, C.R.; Cook, L.B.; Melamed, A. HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin. Cancer Biol. 2014, 26, 89-98. [CrossRef] [PubMed]
67. Satou, Y.; Miyazato, P.; Ishihara, K.; Yaguchi, H.; Melamed, A.; Miura, M.; Fukuda, A.; Nosaka, K.; Watanabe, T.; Rowan, A.G. et al. The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome. Proc. Natl. Acad. Sci. USA 2016, 113, 3054-3059. [CrossRef] [PubMed]
68. Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693-705. [CrossRef] [PubMed]
69. Li, B.; Carey, M.; Workman, J.L. The role of chromatin during transcription. Cell 2007, 128, 707-719. [CrossRef] [PubMed]
70. Deaton, A.M.; Bird, A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25, 1010-1022. [CrossRef] [PubMed]
71. Kitamura, T.; Takano, M.; Hoshino, H.; Shimotohno, K.; Shimoyama, M.; Miwa, M.; Takaku, F.; Sugimura, T. Methylation pattern of human T-cell leukemia virus in vivo and in vitro: Px and LTR regions are hypomethylated in vivo. Int. J. Cancer 1985, 35, 629-635. [CrossRef] [PubMed]
72. Saggioro, D.; Panozzo, M.; Chieco-Bianchi, L. Human t-lymphotropic virus type i transcriptional regulation by methylation. Cancer Res. 1990, 50, 4968-4973. [PubMed]
73. Koiwa, T.; Hamano-Usami, A.; Ishida, T.; Okayama, A.; Yamaguchi, K.; Kamihira, S.; Watanabe, T. 51-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 2002, 76, 9389-9397. [CrossRef] [PubMed]
74. Zhou, Q.; Li, T.; Price, D.H. RNA polymerase ii elongation control. Annu. Rev. Biochem. 2012, 81, 119-143. [CrossRef] [PubMed]
75. Geiger, T.R.; Sharma, N.; Kim, Y.M.; Nyborg, J.K. The human T-cell leukemia virus type 1 Tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB. Mol. Cell. Biol. 2008, 28, 1383-1392. [CrossRef] [PubMed]
76. Lemasson, I.; Polakowski, N.J.; Laybourn, P.J.; Nyborg, J.K. Tax-dependent displacement of nucleosomes during transcriptional activation of human T-cell leukemia virus type 1. J. Biol. Chem. 2006, 281, 13075-13082. [CrossRef] [PubMed]
77. Sharma, N.; Nyborg, J.K. The coactivators CBP/p300 and the histone chaperone nap1 promote transcription-independent nucleosome eviction at the HTLV-1 promoter. Proc. Natl. Acad. Sci. USA 2008, 105, 7959-7963. [CrossRef] [PubMed]
78. Easley, R.; Carpio, L.; Guendel, I.; Klase, Z.; Choi, S.; Kehn-Hall, K.; Brady, J.N.; Kashanchi, F. Human t-lymphotropic virus type 1 transcription and chromatin-remodeling complexes. J. Virol. 2010, 84, 4755-4768. [CrossRef] [PubMed]
79. Lemasson, I.; Polakowski, N.J.; Laybourn, P.J.; Nyborg, J.K. Transcription factor binding and histone modifications on the integrated proviral promoter in human T-cell leukemia virus-i-infected T-cells. J. Biol. Chem. 2002, 277, 49459-49465. [CrossRef] [PubMed]
80. Lemasson, I.; Polakowski, N.J.; Laybourn, P.J.; Nyborg, J.K. Transcription regulatory complexes bind the human T-cell leukemia virus 51 and 31 long terminal repeats to control gene expression. Mol. Cell. Biol. 2004, 24, 6117-6126. [CrossRef] [PubMed]
81. Taniguchi, Y.; Nosaka, K.; Yasunaga, J.; Maeda, M.; Mueller, N.; Okayama, A.; Matsuoka, M. Silencing of human T-cell leukemia virus type i gene transcription by epigenetic mechanisms. Retrovirology 2005, 2, 64. [CrossRef] [PubMed]
82. Barski, A.; Cuddapah, S.; Cui, K.; Roh, T.Y.; Schones, D.E.; Wang, Z.; Wei, G.; Chepelev, I.; Zhao, K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129, 823-837. [CrossRef] [PubMed]
83. Moore, M.J.; Proudfoot, N.J. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 2009, 136, 688-700. [CrossRef] [PubMed]
84. Bell, A.C.; Felsenfeld, G. Methylation of a CTCF-dependent boundary controls imprinted expression of the igf2 gene. Nature 2000, 405, 482-485. [PubMed]
85. Hark, A.T.; Schoenherr, C.J.; Katz, D.J.; Ingram, R.S.; Levorse, J.M.; Tilghman, S.M. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/IGF2 locus. Nature 2000, 405, 486-489. [PubMed]
86. Ong, C.T.; Corces, V.G. CTCF: An architectural protein bridging genome topology and function. Nat. Rev. Genet. 2014, 15, 234-246. [CrossRef] [PubMed]
87. de Wit, E.; Vos, E.S.; Holwerda, S.J.; Valdes-Quezada, C.; Verstegen, M.J.; Teunissen, H.; Splinter, E.; Wijchers, P.J.; Krijger, P.H.; de Laat, W. CTCF binding polarity determines chromatin looping. Mol. Cell 2015, 60, 676-684. [CrossRef] [PubMed]
88. Wendt, K.S.; Yoshida, K.; Itoh, T.; Bando, M.; Koch, B.; Schirghuber, E.; Tsutsumi, S.; Nagae, G.; Ishihara, K.; Mishiro, T. et al. Cohesin mediates transcriptional insulation by ccctc-binding factor. Nature 2008, 451, 796-801. [CrossRef]
89. Rao, S.S.; Huntley, M.H.; Durand, N.C.; Stamenova, E.K.; Bochkov, I.D.; Robinson, J.T.; Sanborn, A.L.; Machol, I.; Omer, A.D.; Lander, E.S. et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 2014, 159, 1665-1680. [CrossRef] [PubMed]
90. Tang, Z.; Luo, O.J.; Li, X.; Zheng, M.; Zhu, J.J.; Szalaj, P.; Trzaskoma, P.; Magalska, A.; Wlodarczyk, J.; Ruszczycki, B. et al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell 2015, 163, 1611-1627. [CrossRef] [PubMed]
91. Kang, H.; Cho, H.; Sung, G.H.; Lieberman, P.M. CTCF regulates kaposi’s sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. J. Virol. 2013, 87, 1789-1799. [CrossRef] [PubMed]
92. Tempera, I.; Lieberman, P.M. Epigenetic regulation of ebv persistence and oncogenesis. Semin. Cancer Biol. 2014, 26, 22-29. [CrossRef] [PubMed]
93. Lieberman, P.M. Chromatin structure of epstein-barr virus latent episomes. Curr. Top. Microbiol. Immunol. 2015, 390, 71-102. [PubMed]
94. Kim, T.H.; Abdullaev, Z.K.; Smith, A.D.; Ching, K.A.; Loukinov, D.I.; Green, R.D.; Zhang, M.Q.; Lobanenkov, V.V.; Ren, B. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 2007, 128, 1231-1245. [CrossRef] [PubMed]
95. Yoshida, M.; Seiki, M.; Yamaguchi, K.; Takatsuki, K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. USA 1984, 81, 2534-2537. [CrossRef] [PubMed]
96. Etoh, K.; Tamiya, S.; Yamaguchi, K.; Okayama, A.; Tsubouchi, H.; Ideta, T.; Mueller, N.; Takatsuki, K.; Matsuoka, M. Persistent clonal proliferation of human t-lymphotropic virus type 1-infected cells in vivo. Cancer Res. 1997, 57, 4862-4867. [PubMed]
97. Doi, K.; Wu, X.; Taniguchi, Y.; Yasunaga, J.; Satou, Y.; Okayama, A.; Nosaka, K.; Matsuoka, M. Preferential selection of human T-cell leukemia virus type 1 provirus integration sites in leukemic versus carrier states. Blood 2005, 106, 1048-1053. [CrossRef] [PubMed]
98. Meekings, K.N.; Leipzig, J.; Bushman, F.D.; Taylor, G.P.; Bangham, C.R. HTLV-1 integration into transcriptionally active genomic regions is associated with proviral expression and with HAM/TSP. PLoS Pathog. 2008, 4, e1000027. [CrossRef] [PubMed]
99. Firouzi, S.; Lopez, Y.; Suzuki, Y.; Nakai, K.; Sugano, S.; Yamochi, T.; Watanabe, T. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med. 2014, 6, 46. [CrossRef] [PubMed]
100. Gillet, N.A.; Gutierrez, G.; Rodriguez, S.M.; de Brogniez, A.; Renotte, N.; Alvarez, I.; Trono, K.; Willems, L. Massive depletion of bovine leukemia virus proviral clones located in genomic transcriptionally active sites during primary infection. PLoS Pathog. 2013, 9, e1003687. [CrossRef] [PubMed]
101. Daenke, S.; Nightingale, S.; Cruickshank, J.K.; Bangham, C.R. Sequence variants of human T-cell lymphotropic virus type i from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J. Virol. 1990, 64, 1278-1282. [PubMed]
102. Konishi, H.; Kobayashi, N.; Hatanaka, M. Defective human T-cell leukemia virus in adult T-cell leukemia patients. Mol. Biol. Med. 1984, 2, 273-283. [PubMed]
103. Manzari, V.; Wong-Staal, F.; Franchini, G.; Colombini, S.; Gelmann, E.P.; Oroszlan, S.; Staal, S.; Gallo, R.C. Human T-cell leukemia-lymphoma virus (HTLV): Cloning of an integrated defective provirus and flanking cellular sequences. Proc. Natl. Acad. Sci. USA 1983, 80, 1574-1578. [CrossRef] [PubMed]
104. Tamiya, S.; Matsuoka, M.; Etoh, K.; Watanabe, T.; Kamihira, S.; Yamaguchi, K.; Takatsuki, K. Two types of defective human t-lymphotropic virus type i provirus in adult T-cell leukemia. Blood 1996, 88, 3065-3073. [PubMed]
105. Miyazaki, M.; Yasunaga, J.; Taniguchi, Y.; Tamiya, S.; Nakahata, T.; Matsuoka, M. Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 51 long terminal repeat during oncogenesis. J. Virol. 2007, 81, 5714-5723. [CrossRef] [PubMed]
106. Fan, J.; Ma, G.; Nosaka, K.; Tanabe, J.; Satou, Y.; Koito, A.; Wain-Hobson, S.; Vartanian, J.P.; Matsuoka, M. Apobec3g generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J. Virol. 2010, 84, 7278-7287. [CrossRef] [PubMed]
107. Grassmann, R.; Aboud, M.; Jeang, K.T. Molecular mechanisms of cellular transformation by HTLV-1 tax. Oncogene 2005, 24, 5976-5985. [CrossRef] [PubMed]